Eurocommercial Properties N.V.
Eurocommercial Properties N.V. will be announcing its 31 December 2020 Results on Friday 26 March 2021.
The Company will host a conference call and audio webcast for investors and analysts starting at 10:00 AM (GMT) / 11:00 AM (CET), and we would be delighted if you could join.
To access the call, you will be asked to pre-register by clicking on the link: http://emea.directeventreg.com/registration/9391820
Participants must register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial In Numbers, Direct Event Passcode and unique Registrant ID.
Call reminders will also be sent to registered participants via email the day prior to the event. Please provide this registration information to those participants that you would like to attend your call.
In the 10 minutes prior to call start time, Participants will need to use the conference access information provided in the email received at the point of registering.
The call will also be audio webcast at https://www.eurocommercialproperties.com/financial/webcast
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd24.12.2025 14:36:11 CET | Press release
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
The Magnum Ice Cream Company N.V.24.12.2025 11:52:30 CET | Press release
Director/PDMR Shareholding
Afarak Group SE24.12.2025 10:00:00 CET | Press release
AFARAK GROUP SE: DISTRIBUTION OF ASSETS FROM THE RESERVE FOR INVESTED UNRESTRICTED EQUITY
Sanofi Winthrop Industrie24.12.2025 07:15:00 CET | Press release
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
FLSmidth A/S24.12.2025 07:00:00 CET | Press release
FLSmidth: Transactions under share buy-back programme
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
